What is CapsoVision?
CapsoVision, Inc. (capsovision.com) is a privately held company dedicated to advancing medical technologies. Operating from Silicon Valley, California, CapsoVision focuses on developing innovative solutions that empower physicians and patients, aiming to improve diagnostic accuracy and clinical outcomes. Their flagship product, the CapsoCam Plus capsule endoscopy system, is currently distributed in over 70 countries, reflecting a substantial global reach and market penetration in the medical device sector.
How much funding has CapsoVision raised?
CapsoVision has raised a total of $74.2M across 11 funding rounds:
Private Equity
$2.5M
Private Equity
$1.5M
Private Equity
$589K
Private Equity
$3.7M
Private Equity
$15.9M
Private Equity
$4.6M
Debt
$350K
IPO
$27.5M
Stock/Share Issuance
$14M
Private Equity (2011): $2.5M, investors not publicly disclosed
Private Equity (2011): $1.5M, investors not publicly disclosed
Private Equity (2012): $589K, investors not publicly disclosed
Private Equity (2012): $3.7M, investors not publicly disclosed
Private Equity (2014): $15.9M, investors not publicly disclosed
Private Equity (2016): $4.6M, investors not publicly disclosed
Debt (2020): $350K featuring PPP
IPO (2025): $27.5M, investors not publicly disclosed
Stock/Share Issuance (2026): $14M, investors not publicly disclosed
What's next for CapsoVision?
The substantial enterprise-level backing and recent strategic investment position CapsoVision for accelerated growth and further innovation in capsule endoscopy. This infusion of capital is likely to fuel expanded research and development efforts, enhance global market penetration, and potentially support strategic acquisitions or partnerships. The company's trajectory suggests a focus on scaling its operations to meet increasing demand for its diagnostic technologies, solidifying its role as a key player in the medical device industry.
See full CapsoVision company page
